Dyadic International, Inc., a global biotechnology company focused on the discovery, development, manufacture and sale of enzymes and other proteins for the bioenergy, bio-based chemicals, biopharmaceutical, food and feed industries, announced that it has launched Fibrezyme G4, a high performance cellulase enzyme product designed to enhance paper and textile quality, while improving the economics of our customers’ manufacturing processes.
Fibrezyme G4 has shown to reduce energy requirements and increase production rates for pulp and paper manufacturers. In addition, Fibrezyme G4 enhances and restores fiber strength and increases inter-fiber bonding in paper-making applications. In the textile industry, Fibrezyme G4 will be used to soften denim and create a stonewashed look for blue jeans. Fibrezyme G4 operates under wide pH and temperature ranges allowing for improved integration into a variety of pulp and paper and textile manufacturing processes.
Danai Brooks, Dyadic’s Chief Operating Officer stated, "Fibrezyme G4 is a new addition to our product portfolio and provides further evidence of the capabilities of Dyadic’s C1 platform technology. We expect two key markets to be China and South Asia, which are growing and open to new entrants like Dyadic. Interest in pulp and paper enzymes in South Asia continues to grow in both commercial applications and innovation.
“South Asia is also one of the world’s largest textile enzyme markets. Over the past year, China has become an important part of our pulp and paper strategy as we continue to strengthen our commercial relationships in that country. In addition, government policy is increasingly focused on the environmental impact of mills, which is expected to drive up demand for enzymes like Fibrezyme G4.”
Dyadic's Vice President of Operations, Rich Jundzil, added “Fibrezyme G4 represents the next generation of C1-based products produced using the White Strain, the latest addition to Dyadic's patented and proprietary C1 platform. In our manufacturing process, the White Strain produces purer proteins, which allows us to make more of the protein of interest with a reduction in unwanted side activities.
This technology allows for more efficient industrial scale production of highly targeted enzymes that are specifically designed to meet the needs of our customers. The White Strain continues to broaden the reach of the C1 platform into new applications for the pharmaceutical, food, animal feed, brewing, baking, and other industrial markets.” Fibrezyme G4 became available to customers beginning in March of 2014.